Sales & Marketing News | pharmaphorum

News

Sanofi to invest €1bn in France to lift ‘health sovereignty’

Sanofi will invest more than €1 billion ($1.08 billion) in new bioproduction capacity at three manufacturing sites in France as part of a €3.5 billion programme in the cou

News

FDA delays decision on Moderna’s RSV vaccine

Moderna’s first attempt to expand its commercial activities beyond COVID-19 vaccines, its respiratory syncytial virus (RSV) shot, has suffered a delay in the US.

News

Sanofi forges $1.2bn alliance with vaccines firm Novavax

Sanofi has licensed joint commercial rights to Novavax’s COVID-19 vaccine and will work with the biotech on the development of combined flu/COVID shots in a deal worth up

News

Spectral AI nears first sales of wound care system

Spectral AI is on the brink of becoming a commercial-stage company, with the first sales of its DeepView wound imaging system due to start in its first market, the UK, lat

News

Sorcero GenAI conjures plain language from scientific papers

Understanding complex scientific studies is often a challenge for patients as well as healthcare professionals, but one that may become easier thanks to artificial intelli

News

Citi analyst Andrew Baum to head Pfizer strategy team

Pfizer will draw on the expertise of Citi analyst Andrew Baum when it comes to portfolio management and capital deployment, naming him chief strategy and innovation office

Sanofi to invest €1bn in France to lift ‘health sovereignty’

FDA delays decision on Moderna’s RSV vaccine

Sanofi forges $1.2bn alliance with vaccines firm Novavax

Spectral AI nears first sales of wound care system

Sorcero GenAI conjures plain language from scientific papers

Citi analyst Andrew Baum to head Pfizer strategy team

Gilead strikes again, penning $5bn deal to buy Tubulis

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks